Thursday, Dec 03, 2020 | Last Update : 04:12 AM IST

antiviral drug

India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients

13 Aug 2020 11:01 AM

Glenmark's Favipiravir shows positive results in Phase-3 COVID-19 trial

The results also demonstrated 40 per cent faster achievement of 'clinical cure' defined as the physician's assessment of normalization

23 Jul 2020 9:40 AM

Cipla to price remdesivir version for COVID-19 under Rs 5,000

Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the year.

24 Jun 2020 9:16 AM

Is a cure for HIV inching closer? Scientists discover new possibility

Team creates neutralising antibody, effective not only against all genetically divergent global HIV-1 strains, but also on latent cells.

08 May 2018 1:28 PM

ADVERTISEMENT
ADVERTISEMENT